U.S., March 19 -- An application to own the trademark for 'ASCENT' has been filed on Aug. 24, 2020.
Owner(s):
RegenxBio Inc.; 9804 Medical Center Drive, , Maryland
Goods and/or Services:
For: Medical and scientific research, namely, conducting clinical trials for others, all the above for gene therapy, namely for use in the
treatment of wet age-related macular degeneration (AMD) using subretinal delivery
Class(es): 100, 101
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-03-18&serialNumber=90133732
Disclaimer: Curated by HT Syndication....